Colonic Cytokinetics and Cell Signaling: Dietary Effects
结肠细胞动力学和细胞信号传导:饮食影响
基本信息
- 批准号:8028385
- 负责人:
- 金额:$ 25.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-12-23 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvant TherapyAdoptedAdverse effectsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApoptosisApoptoticArachidonic AcidsAttenuatedAzoxymethaneBindingButyratesCardiolipinsCaveolaeCell Death Signaling ProcessCell LineChemoprotective AgentClinicalCohort StudiesColonColon CarcinomaColonic NeoplasmsColorectal AdenomaColorectal CancerConsumptionCounselingCoxibsDataDevelopmentDietDietary FatsDietary FiberDinoprostoneDocosahexaenoic AcidsEP4 receptorEicosapentaenoic AcidEpidemiologic StudiesEpidemiologyEpidermal Growth Factor ReceptorExperimental ModelsFailureFatty AcidsFatty acid glycerol estersFermentationFiberFish OilsFundingFutureGoalsGuanine NucleotidesHumanHydrogen PeroxideIn VitroLaboratoriesLinoleic AcidsLipidsLiteratureMalignant - descriptorMediatingMembraneMembrane LipidsMembrane MicrodomainsMitochondriaMolecularMolecular Mechanisms of ActionMolecular TargetMorphologyMusNutrientNutritionalObservational StudyOncogenicOutcomeOxygenPTEN genePatientsPectinsPermeabilityPharmaceutical PreparationsPhospholipidsPlayPolyunsaturated Fatty AcidsPropertyProstaglandin-Endoperoxide SynthaseProstaglandins EProteinsProto-Oncogene Proteins c-aktReceptor SignalingRoleSOD2 geneSeriesSignal TransductionSignaling ProteinStressStructureSuperoxide DismutaseSurfaceTestingTimeTransgenic MiceWorkbioactive food componentcancer preventioncancer riskdosageeicosanoid metabolismextracellularin vivomitochondrial membranemouse modelnoveloxidationpalmitoylationprospectiveprostaglandin E3prostaglandin EP2 receptorprotective effectprotein transportras Proteinsreceptorsegregationsystematic reviewtumorigenesis
项目摘要
DESCRIPTION (provided by applicant):
There are cogent data indicating a protective effect of n-3 polyunsaturated fatty acids (PUFA) e.g., eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on colon cancer. In contrast, dietary lipids rich in n-6 PUFA, e.g., linoleic acid (LA) and arachidonic acid (AA), enhance the development of colon tumors. This is significant because the typical Western diet contains 10 to 20 times more n-6 than n-3 PUFA. Unfortunately, to date, a unifying mechanistic hypothesis addressing why n-3 PUFA selectively suppress colon cancer compared to n-6 PUFA (the major dietary form of PUFA in the U.S. diet) is lacking. In the current funding period, we demonstrated that (i) dietary n-3 PUFA induce perturbations in colonocyte membrane microdomain (caveolae) lipid composition, suppressing oncogenic signaling and Ras protein trafficking; (ii) n-3 PUFA supplant arachidonic acid (AA) in colonocyte membrane phospholipids, with EPA in particular being metabolized into a novel 3-series E-prostaglandin (PGE3), a putative antitumorigenic-cyclooxygenase (COX) metabolite; and (iii) the proapoptotic- chemoprotective effect of n-3 PUFA is enhanced when a highly fermentable fiber, pectin (or its fermentation product-butyrate) is added to the diet. We postulate that the failure to address an interaction between dietary fat and fiber may explain why the chemoprotective effects of fiber are obscured in prospective cohort studies. Therefore, the overall goal of this proposal is to further elucidate how dietary n-3 PUFA and fermentable fiber up-regulate apoptosis effector mechanisms in colonocytes, thereby reducing colon cancer risk. An array of experimental models will be used, including in vivo (azoxymethane-injected oxidatively stressed SOD2+/-, Gpx4+/- knock outs, Gpx4Tg and fat-1 transgenic mouse models) and in vitro (normal and malignant transformed mouse and human colonocyte cell lines) in order to test our primary hypothesis that n-3 PUFA and butyrate work in a coordinated manner to potentiate mitochondrial-mediated apoptosis. As a complementary hypothesis, we propose that DHA and possibly EPA alter colonocyte membrane lipid microdomain composition, thereby favorably modulating eicosanoid metabolism and the relay of extracellular signals from surface receptors to downstream signaling networks. The following specific aims are proposed: Aim #1 will determine the mechanisms by which n-3 PUFA and butyrate interaction modulate intrinsic (mitochondria-mediated) cell death signaling in the colon; Aim #2 will determine the mechanisms by which n-3 PUFA alter the spatio-temporal segregation of Ras-dependent signals; and Aim #3 will characterize the putative chemoprotective properties of a novel EPA-derived cyclooxygenase product, PGE3. The consumption of EPA and DHA may prove an effective adjuvant therapy in colon cancer. Therefore, it is both appropriate and timely to determine precisely how n-3 PUFA modulate cell signaling networks and reduce colon cancer risk.A growing body of literature supports the contention that bioactive food components containing n-3 polyunsaturated fatty acids (PUFA) are important in suppressing colon cancer. Consistent with the objectives and scope of PA-07-100, Prioritizing molecular targets for cancer prevention with nutritional combinations , the overall goal of this proposal is to elucidate how dietary n-3 PUFA and fermentable fiber up-regulate apoptosis effector mechanisms in colonocytes, thereby reducing colon cancer risk.
描述(由申请人提供):
有令人信服的数据表明n-3多不饱和脂肪酸(PUFA)的保护作用,二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)对结肠癌的作用。相反,富含n-6 PUFA的膳食脂质,例如,亚油酸(LA)和花生四烯酸(AA),促进结肠肿瘤的发展。这是很重要的,因为典型的西方饮食中含有的n-6比n-3多不饱和脂肪酸多10到20倍。不幸的是,到目前为止,还缺乏一个统一的机制假说来解释为什么n-3 PUFA与n-6 PUFA(美国饮食中PUFA的主要饮食形式)相比选择性地抑制结肠癌。在当前的资助期内,我们证明了(i)饮食n-3 PUFA诱导结肠细胞膜微区的扰动(小窝)脂质组合物,抑制致癌信号传导和Ras蛋白运输;(ii)n-3 PUFA取代了结肠细胞膜磷脂中的花生四烯酸(AA),特别是EPA被代谢成新的3系列E-前列腺素(PGE 3),推定的抗肿瘤-环氧合酶(考克斯)代谢物;和(iii)当将高度可发酵的纤维、果胶(或其发酵产物-丁酸盐)添加到饮食中时,n-3 PUFA的促凋亡-化学保护作用增强。我们推测,未能解决膳食脂肪和纤维之间的相互作用可能解释为什么纤维的化学保护作用在前瞻性队列研究中被掩盖。因此,该提案的总体目标是进一步阐明膳食n-3 PUFA和可发酵纤维如何上调结肠细胞中的凋亡效应机制,从而降低结肠癌风险。将使用一系列实验模型,包括体内(注射氧化偶氮甲烷的氧化应激SOD 2 +/-、Gpx 4 +/-敲除、Gpx 4 Tg和fat-1转基因小鼠模型)和体外(正常和恶性转化的小鼠和人结肠细胞系),以检验我们的主要假设,即n-3 PUFA和丁酸盐以协调的方式发挥作用,从而增强膀胱介导的细胞凋亡。作为一个互补的假设,我们提出,DHA和可能EPA改变结肠细胞膜脂质微区组成,从而有利地调节类花生酸代谢和细胞外信号从表面受体到下游信号网络的中继。提出了以下具体目标:目标1将确定n-3 PUFA和丁酸相互作用调节内源性目的#2将确定n-3 PUFA改变Ras依赖性信号的时空分离的机制;和目标#3将表征新的EPA衍生的环氧合酶产物PGE 3的推定化学保护性质。EPA和DHA的消耗可能被证明是结肠癌的有效辅助治疗。因此,研究n-3多不饱和脂肪酸(n-3 polyunsaturated fatty acids,PUFA)对细胞信号通路的调控作用,降低结肠癌发生的风险,是一个非常重要的课题。与PA-07-100的目标和范围一致,通过营养组合优先考虑癌症预防的分子靶点,本提案的总体目标是阐明膳食n-3 PUFA和可发酵纤维如何上调结肠细胞中的凋亡效应机制,从而降低结肠癌风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Stephen Chapkin其他文献
Robert Stephen Chapkin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Stephen Chapkin', 18)}}的其他基金
Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
早产儿肠道成熟和喂养耐受性的营养和临床预测因素
- 批准号:
10717469 - 财政年份:2023
- 资助金额:
$ 25.61万 - 项目类别:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
靶向质膜空间动力学抑制异常的 Wnt 信号传导
- 批准号:
10047029 - 财政年份:2020
- 资助金额:
$ 25.61万 - 项目类别:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
靶向质膜空间动力学抑制异常的 Wnt 信号传导
- 批准号:
10401939 - 财政年份:2020
- 资助金额:
$ 25.61万 - 项目类别:
Diet and the colonic exfoliome: a novel, non-invasive approach to testing interventions in humans
饮食和结肠脱落组:一种测试人类干预措施的新型非侵入性方法
- 批准号:
10603601 - 财政年份:2020
- 资助金额:
$ 25.61万 - 项目类别:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
靶向质膜空间动力学抑制异常的 Wnt 信号传导
- 批准号:
10630909 - 财政年份:2020
- 资助金额:
$ 25.61万 - 项目类别:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
靶向质膜空间动力学抑制异常的 Wnt 信号传导
- 批准号:
10252842 - 财政年份:2020
- 资助金额:
$ 25.61万 - 项目类别:
Dietary Flavonoids-Microbiota-Ah Receptor Interactions in the Gut
肠道中膳食黄酮类化合物-微生物群-Ah 受体的相互作用
- 批准号:
9791345 - 财政年份:2018
- 资助金额:
$ 25.61万 - 项目类别:
Dietary Flavonoids-Microbiota-Ah Receptor Interactions in the Gut
肠道中膳食黄酮类化合物-微生物群-Ah 受体的相互作用
- 批准号:
10247052 - 财政年份:2018
- 资助金额:
$ 25.61万 - 项目类别:
Dietary and microbial predictors of childhood obesity risk
儿童肥胖风险的饮食和微生物预测因素
- 批准号:
9892995 - 财政年份:2017
- 资助金额:
$ 25.61万 - 项目类别:
Role of Aryl Hydrocarbon Receptor in Microbiota-Colon Stem Cell Interactions
芳基烃受体在微生物群-结肠干细胞相互作用中的作用
- 批准号:
9102325 - 财政年份:2016
- 资助金额:
$ 25.61万 - 项目类别:
相似海外基金
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 25.61万 - 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
- 批准号:
494901 - 财政年份:2023
- 资助金额:
$ 25.61万 - 项目类别:
Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
- 批准号:
10714537 - 财政年份:2023
- 资助金额:
$ 25.61万 - 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
- 批准号:
10588103 - 财政年份:2023
- 资助金额:
$ 25.61万 - 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
- 批准号:
22K09407 - 财政年份:2022
- 资助金额:
$ 25.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
- 批准号:
21KK0287 - 财政年份:2022
- 资助金额:
$ 25.61万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
- 批准号:
10357120 - 财政年份:2022
- 资助金额:
$ 25.61万 - 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
- 批准号:
21K08700 - 财政年份:2021
- 资助金额:
$ 25.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
- 批准号:
437315 - 财政年份:2020
- 资助金额:
$ 25.61万 - 项目类别:
Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
- 批准号:
435603 - 财政年份:2020
- 资助金额:
$ 25.61万 - 项目类别:
Operating Grants